A Prospective Intervention Study on Higher-Dose Oseltamivir Treatment in Adults Hospitalized With Influenza A and B Infections

Global Assessment of Resistance to Neuraminidase Inhibitors, 2008–2011: The Influenza Resistance Information Study (IRIS)

(2013) Richard J. Whitley et al.   CLINICAL INFECTIOUS DISEASES

Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial

(2013)   BMJ-British Medical Journal

Diagnosis, management and outcomes of adults hospitalized with influenza

(2012) Nelson Lee et al.   ANTIVIRAL THERAPY

Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods

(2012) Ha T Nguyen et al.   ANTIVIRAL THERAPY

Influenza B Lineage Circulation and Hospitalization Rates in a Subtropical City, Hong Kong, 2000–2010

(2012) Paul K. S. Chan et al.   CLINICAL INFECTIOUS DISEASES

A Cluster of Patients Infected With I221V Influenza B Virus Variants With Reduced Oseltamivir Susceptibility—North Carolina and South Carolina, 2010–2011

(2012) Shikha Garg et al.   JOURNAL OF INFECTIOUS DISEASES

Antiviral Therapy and Outcomes of Patients with Pneumonia Caused by Influenza A Pandemic (H1N1) Virus

(2012) Shi-gui Yang et al.   PLoS One

Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia

(2011) Nelson Lee et al.   ANTIVIRAL THERAPY

Complications and Outcomes of Pandemic 2009 Influenza A (H1N1) Virus Infection in Hospitalized Adults: How Do They Differ From Those in Seasonal Influenza?

(2011) N. Lee et al.   JOURNAL OF INFECTIOUS DISEASES

Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza

(2010) R. E. Ariano et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Oseltamivir in Seasonal, Avian H5N1 and Pandemic 2009 A/H1N1 Influenza

(2010) Nicolas Widmer et al.   CLINICAL PHARMACOKINETICS

Safety and pharmacokinetics of oseltamivir at standard and high dosages

(2010) R. Dutkowski et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations

(2010) B. E. Davies   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

End Points for Testing Influenza Antiviral Treatments for Patients at High Risk of Severe and Life‐Threatening Disease

(2010) Michael G. Ison et al.   JOURNAL OF INFECTIOUS DISEASES

Development and comparison of molecular assays for the rapid detection of the pandemic influenza A (H1N1) 2009 virus

(2010) Wai-Yip Lam et al.   JOURNAL OF MEDICAL VIROLOGY

Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Outcomes of adults hospitalised with severe influenza

(2010) N. Lee et al.   THORAX

Prediction of the Pharmacodynamically Linked Variable of Oseltamivir Carboxylate for Influenza A Virus Using an In Vitro Hollow-Fiber Infection Model System

(2009) J. J. McSharry et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Studies on the influence of esterase inhibitor to the pharmacokinetic profiles of oseltamivir and oseltamivir carboxylate in rats using an improved LC/MS/MS method

(2009) Qi Chang et al.   BIOMEDICAL CHROMATOGRAPHY

Viral Loads and Duration of Viral Shedding in Adult Patients Hospitalized with Influenza

(2009) Nelson Lee et al.   JOURNAL OF INFECTIOUS DISEASES

Low Penetration of Oseltamivir and Its Carboxylate into Cerebrospinal Fluid in Healthy Japanese and Caucasian Volunteers

(2008) S. S. Jhee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics of High-Dose Oseltamivir in Healthy Volunteers

(2008) Y. Wattanagoon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison of the Clinical Effectiveness of Oseltamivir and Zanamivir against Influenza Virus Infection in Children

(2008) Norio Sugaya et al.   CLINICAL INFECTIOUS DISEASES

Diagnostic Testing or Empirical Therapy for Patients Hospitalized with Suspected Influenza: What to Do?

(2008) Allison J. McGeer   CLINICAL INFECTIOUS DISEASES

Developing New Antiviral Agents for Influenza Treatment: What Does the Future Hold?

(2008) Frederick Hayden   CLINICAL INFECTIOUS DISEASES

Oseltamivir Is Adequately Absorbed Following Nasogastric Administration to Adult Patients with Severe H5N1 Influenza

(2008) Walter R. J. Taylor et al.   PLoS One